CompanyGraph
What stands out
- Earnings significantly exceed cash generation
At a glance
- Depends onDownstream position: depends on 11 industries, supplies 6
- ScaleMarket cap is $11.63B, above the global median of $1.15B
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.21%Above 5Y avg (0.96%)
Annual Rate
CNY 1.57Paid annual
Payout Ratio
102.2%High
Payback Period
79.0 yr
Last Ex-Dividend
Jul 31, 2026
The reported statements, read against the company's own industry.
What stands out
- Earnings significantly exceed cash generation
Financials view
Market Capitalization
78.22BCNY11.63B · vs all stocks (USD)
Trailing P/E
40.41xRevenue (TTM)
8.60BCNY1.28B · vs all stocks (USD)
Profit Margin
22.12%Beta
0.2410xvs all stocks
52-Week Change
-39.49%vs all stocks
Market Capitalization
78.22BCNY11.63B · vs all stocks (USD)
Enterprise Value
76.46BCNY11.37B · vs all stocks (USD)
Trailing P/E
40.41xForward P/E
26.14xPEG Ratio
-1.56xPrice to Sales (TTM)
8.93xPrice to Book (MRQ)
5.05xEnterprise to Revenue
8.89xEnterprise to EBITDA
38.90xGross Margin
42.18%Profit Margin
22.12%Operating Margin
30.62%Return on Assets (TTM)
6.37%Return on Equity (TTM)
11.83%Revenue (TTM)
8.60BCNY1.28B · vs all stocks (USD)
Revenue per Share (TTM)
14.25CNYUpdated Aug 20, 2026Quarterly Revenue Growth
-12.70%Gross Profit (TTM)
3.01BCNY447.69M · vs all stocks (USD)
EBITDA (TTM)
2.73BCNY405.63M · vs all stocks (USD)
Net Income (TTM)
1.90BCNY282.90M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-25.60%Operating Cash Flow (TTM)
451.06MCNY67.08M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
2.15BCNY320.03M · vs all stocks (USD)
Trailing Annual Dividend Rate
1.57CNYUpdated Aug 20, 2026Trailing Annual Dividend Yield
1.21%vs all stocks
5-Year Average Dividend Yield
0.96%vs all stocks
Payout Ratio
102.22%Minority Interest (Equity)
548.58MCNYFY2025 · Dec 31, 2025Revenue
9.00BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
5.72BCNYFY2025 · Dec 31, 2025Gross Profit
3.28BCNYFY2025 · Dec 31, 2025Operating Income
2.25BCNY334.60M · vs all stocks (USD)
Pre-tax Income
2.54BCNYFY2025 · Dec 31, 2025Income Tax Expense
394.55MCNYFY2025 · Dec 31, 2025Net Income
2.14BCNYFY2025 · Dec 31, 2025EBIT
2.57BCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
2.73BCNYFY2025 · Dec 31, 2025Research & Development
252.23MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
276.47MCNYFY2025 · Dec 31, 2025Other Operating Expenses
49.35MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
14.39MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
31.75MCNYFY2025 · Dec 31, 2025EPS (Basic)
3.58CNYFY2025 · Dec 31, 2025EPS (Diluted)
3.58CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
602.97MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
602.97MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
2.14BCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
15.35MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
495.42MCNYFY2025 · Dec 31, 2025Free Cash Flow
159.07MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
1.22BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
2.14BCNYFY2025 · Dec 31, 2025Other Non-cash Items
41.13MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-50.42MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-1.64BCNYFY2025 · Dec 31, 2025Capital Expenditures
-336.36MCNYFY2025 · Dec 31, 2025Purchase of Investments
-229.25MCNYFY2025 · Dec 31, 2025Sale of Investments
30.04MCNYFY2025 · Dec 31, 2025Other Investing Activity
2.27BCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
1.74BCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
910.34MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-966.26MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-1.97BCNYFY2025 · Dec 31, 2025Other Financing Charges
-49.47MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-2.07BCNYFY2025 · Dec 31, 2025Shares Outstanding
603.32MSharesUpdated Aug 20, 2026Float Shares
247.24MSharesUpdated Aug 20, 2026% Held by Insiders
62.37%vs all stocks
% Held by Institutions
5.27%vs all stocks
Total Cash (MRQ)
1.96BCNY291.00M · vs all stocks (USD)
Total Cash per Share (MRQ)
3.24CNYUpdated Aug 20, 2026Total Debt (MRQ)
1.07BCNY158.83M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0678xCurrent Ratio (MRQ)
5.02xBook Value per Share (MRQ)
25.21CNYUpdated Aug 20, 2026Total Assets
17.56BCNY2.61B · vs all stocks (USD)
Total Current Assets
10.67BCNYFY2025 · Dec 31, 2025Total Liabilities
2.47BCNYFY2025 · Dec 31, 2025Total Non-current Assets
6.89BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
347.37MCNYFY2025 · Dec 31, 2025Total Current Liabilities
2.12BCNYFY2025 · Dec 31, 2025Cash
1.20BCNYFY2025 · Dec 31, 2025Cash Equivalents
59.57MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
1.26BCNYFY2025 · Dec 31, 2025Accounts Receivable
753.17MCNYFY2025 · Dec 31, 2025Inventory
6.68BCNYFY2025 · Dec 31, 2025Accounts Payable
548.68MCNYFY2025 · Dec 31, 2025Short-term Debt
878.42MCNYFY2025 · Dec 31, 2025Other Current Liabilities
17.30MCNYFY2025 · Dec 31, 2025Long-term Debt
183.74MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
31.23MCNYFY2025 · Dec 31, 2025Common Stock (Book)
603.32MCNYFY2025 · Dec 31, 2025Retained Earnings
10.62BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
15.09BCNY2.24B · vs all stocks (USD)
52-Week Low
105.98CNYUpdated Aug 20, 202652-Week High
215.02CNYUpdated Aug 20, 202652-Week Change
-39.49%vs all stocks
Beta
0.2410xvs all stocks
50-Day MA
125.78CNYUpdated Aug 20, 2026200-Day MA
149.68CNYUpdated Aug 20, 2026Avg 10-Day Volume
5.56MSharesUpdated Aug 20, 2026Avg 30-Day Volume
9.07MSharesUpdated Aug 20, 2026Diluted EPS (TTM)
3.15CNYUpdated Aug 20, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Earnings significantly exceed cash generationSignificant
Net Income (USD, TTM): 282,895,967.793Operating Cash Flow (USD, TTM): 67,076,794.731
Supply Chain
Downstream position: depends on 11 industries, supplies 6Notable
Outgoing: 6.00Incoming: 11.00
High connectivity hub: 17 industry connectionsNotable
Total Connections: 17.00
Scale
Market cap is $11.63B, above the global median of $1.15BNotable
Market cap (USD): 11,632,106,645.837Global Median: 1,146,734,693.424
Revenue is $1.28B, above the global median of $520.53MNotable
Revenue (USD): 1,279,079,065.129Global Median: 520,528,949.311
Levered free cash flow is $320.03M, above the global median of $16.24MNotable
Levered free cash flow (USD): 320,028,640.65Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Recordati Industria Chimica e Farmaceutica S.p.A.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Haisco Pharmaceutical Group Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
CSPC Pharmaceutical Group Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Biomarin Pharmaceutical Inc.
Tier 1ProductionApproval-Gated PipelineRule
Axsome Therapeutics, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Insulet Corporation
Tier 1ProductionApproval-Gated PipelineRule
Cipla Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Sichuan Kelun Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Cytokinetics, Incorporated
Tier 1ProductionApproval-Gated PipelineRuleRisk
Penumbra Inc.
Tier 1ProductionApproval-Gated PipelineRule